• Falcao RP, Donadi EA. Infection and immunity in sickle cell disease. AMB Rev Assoc Med Bras 1989; 35: 70-4.
• Overturf GD. Infection and immunizations of children with sickle cell disease. Adv Pediatr Infect Dis 1999; 14: 191-218.
• Akanmori BD, Adjei AA, Nyarko AK, Ankra-Badu, G, Gyan B, Yamamoto S. Serum immunoglobulin and complement levels in Ghanaian sickle cell patients in the steady asymptomatic state. East Afr Med J 1991; 68: 378-82.
• Dieye TN, Ndiaye O, Ndiaye BO et al. Complement and serum immunoglobulins in homozygous and heterozygous sickle cell anaemia in Senegal. Dakar Med 1999; 44: 175-9.
• El-Arabi I, Ghafouri H, Serebour F, Saggaff H, Acquaye J. The immunological profile in sickle cell anaemia: a study of patients in the Arab peninsula. Ann Trop Paediatr 1988; 8: 116-21.
• Chudwin DS, Korenblit AD, Kingzette M, Artrip S, Rao S. Increased activation of the alternative complement pathway in sickle cell disease. Clin Immunol Immunopathol. 1985; 37: 93-7.
• Chudwin DS, Papierniak C, Lint TF, Korenblit AD, Activation of the alternative complement pathway by red blood cells from patients with sickle cell disease. Clin Immunol Immunopathol 1994; 71: 199-202.
• Mold C, Tamerius JD, Phillips G Jr. Complement activation during painful crisis in sickle cell anaemia. Clin Immunol Immunopathol 1995; 76: 314-20.
• Natta CL, Outschoorn IM. IgG2 deficiency in sickle cell anaemia. Scand J Haematol 1984; 33: 129-34.
• Adeodu OO, Adekile AD, Jeje AA, Adedeji FA. Serum immunoglobulins A and M in sickle cell patients in IleIfe, Nigeria. East Afr Med J 1989; 66: 631-5.
• Mohamed AO, Nilsson UR, Omar MI, Ronquist G. Lack of evidence for altered complement and immunoglobulin levels in patients with sickle cell anaemia Scand J Clin Lab Invest 1992; 52: 313-16.
• Dacie JV Lewis SM. Practical Haematology 7th Edinburgh, Churchill Livingstone, 2001.
• Salimonu LS Ladipo OA, Adeniran SO, Osunkoya BO. Serum immunoglobulin levels in normal, premature and post mature babies and their mothers. Int’l J Gyn Obstet 1978; 16: 119-23.
• Donadi EA, Carvalho IF, Falcao RP. Circulating immune complexes in sickle cell anaemia J Clin Lab Immunol 1989; 28: 183-5.
• Rao S. Increased activation of the alternative complement pathway in sickle cell disease Clin Immunol Immunopathol 1985; 37: 93-7.
• Jiang H, Wagner E, Zhang H, Frank MM. Complement 1 inhibitor is regulator of the alternative complement pathway. J Exp Med 2001; 194: 1609-16.
• Pincus T. Laboratory tests in rheumatic diseases. In: Klippel JH, Deippe PA (eds). Rheumatology 2nd ed. London, Mosby, 2000; 2: 10.1-10.8
• Verma UN, Misra R, Singh RR, Agarwa SS, Naik S. Serological correlates of inflammation in rheumatoid arthritis: Usefulness of acute phase reactants in monitoring disease activity. J Indian Rheumatol Assoc 2002; 10: 1-4.
• Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
• Allen U, MacKinnon H, Zipursky A, Stevens M. Severe thrombocytopenia in sickle cell crisis. Pediatr Haematol Oncol 1988; 5: 137-41.
• Akinola NO, Stevens SM, Franklin IM, Nash GB, Stuart J. Subclinical ischaemic episodes during the steady state of sickle cell anaemia. J Clin Pathol 1992; 45: 902-6.

Vancouver

L. S, E.A. O, M.A. D. Immuno-haematological characteristics of nigerian sickle cell disease patients in asymptomatic steady state. EUR J GEN MED. 2009;6(3):170-4. https://doi.org/10.29333/ejgm/82664

APA

L., S., E.A., O., & M.A., D. (2009). Immuno-haematological characteristics of nigerian sickle cell disease patients in asymptomatic steady state. European Journal of General Medicine, 6(3), 170-174. https://doi.org/10.29333/ejgm/82664

AMA

L. S, E.A. O, M.A. D. Immuno-haematological characteristics of nigerian sickle cell disease patients in asymptomatic steady state. EUR J GEN MED. 2009;6(3), 170-174. https://doi.org/10.29333/ejgm/82664

Chicago

L., Salawu, Orimolade E.A., and Durosinmi M.A.. "Immuno-haematological characteristics of nigerian sickle cell disease patients in asymptomatic steady state". European Journal of General Medicine 2009 6 no. 3 (2009): 170-174. https://doi.org/10.29333/ejgm/82664

Harvard

L., S., E.A., O., and M.A., D. (2009). Immuno-haematological characteristics of nigerian sickle cell disease patients in asymptomatic steady state. European Journal of General Medicine, 6(3), pp. 170-174. https://doi.org/10.29333/ejgm/82664

MLA

L., Salawu et al. "Immuno-haematological characteristics of nigerian sickle cell disease patients in asymptomatic steady state". European Journal of General Medicine, vol. 6, no. 3, 2009, pp. 170-174. https://doi.org/10.29333/ejgm/82664